Cytokinetics Inc. buy JPMorgan Chase & Co.
Start price
24.06.24
/
50%
€49.60
Target price
24.06.25
€60.52
Performance (%)
-42.74%
End price
25.06.25
€28.40
Summary
This prediction ended on 25.06.25 with a price of €28.40. Massive losses of -42.74% were the result for the BUY prediction by JPMorgan_Chase___Co_. JPMorgan_Chase___Co_ has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | 1.463% | 1.463% | 104.294% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at JPMorgan Chase & Co. from $77.00 to $65.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Cytokinetics Inc.
Stopped prediction by JPMorgan_Chase___Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.00
09.06.25
09.06.25
€46.41
09.06.26
09.06.26
101.52%
10.06.26
10.06.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€50.50
05.09.24
05.09.24
€63.96
05.09.25
05.09.25
-9.31%
06.09.25
06.09.25